Variability of Two Metabolomic Platforms in CKD

BACKGROUND AND OBJECTIVES: Nontargeted metabolomics can measure thousands of low-molecular-weight biochemicals, but important gaps limit its utility for biomarker discovery in CKD. These include the need to characterize technical and intraperson analyte variation, to pool data across platforms, and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin J Am Soc Nephrol
Auteurs principaux: Rhee, Eugene P., Waikar, Sushrut S., Rebholz, Casey M., Zheng, Zihe, Perichon, Regis, Clish, Clary B., Evans, Anne M., Avila, Julian, Denburg, Michelle R., Anderson, Amanda Hyre, Vasan, Ramachandran S., Feldman, Harold I., Kimmel, Paul L., Coresh, Josef
Format: Artigo
Langue:Inglês
Publié: American Society of Nephrology 2019
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364529/
https://ncbi.nlm.nih.gov/pubmed/30573658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07070618
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires